NCT05579366 · Interventional trial
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Overall registry status Recruiting
Phase 1 · Phase 2
Conditions Breast Adenocarcinoma, Cervical Cancer, Endometrial Cancer, Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer (NSCLC), Fallopian Tube Cancer, High Grade Epithelial Ovarian Cancer, High Grade Serous Ovarian Cancer, Hormone Receptor-positive/Her2 Negative Breast Cancer, Mesothelioma, Non-small Cell Lung Cancer, Platinum Sensitive Ovarian Cancer (PSOC), Platinum-resistant Ovarian Cancer (PROC), Primary Peritoneal Carcinoma, Primary Refractory Ovarian Cancer, Triple Negative Breast Cancer, Uterine Cancer
Delaware Valley sites
- MD Anderson Cancer Center at Cooper- Two Cooper Plaza · Camden, NJ · Camden County · Recruiting
- USOR Alliance Cancer Specialist · Doylestown, PA · Bucks County · Recruiting
First posted
Registry updated
Added to the directory